Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,capitalSurplus,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,retainedEarnings,otherLiab,treasuryStock,otherAssets,cash,totalCurrentLiabilities,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,shortTermInvestments,netReceivables,inventory,accountsPayable,investments,changeToLiabilities,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,issuanceOfStock,changeInCash,effectOfExchangeRate,totalCashFromOperatingActivities,depreciation,otherCashflowsFromInvestingActivities,changeToInventory,changeToAccountReceivables,otherCashflowsFromFinancingActivities,changeToNetincome,capitalExpenditures,WC,language,region,quoteType,triggerable,quoteSourceName,currency,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceHint,exchange,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,esgPopulated,tradeable,exchangeDataDelayedBy,shortName,market,marketState,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,longBusinessSummary,city,phone,country,website,maxAge,address1,fax,industry,address2
t0,ICUSF,14737000.0,254142000,4001000,,-4525000,,-4525000,2503000,2205500,-4298500,-4298500,,-22000,,,,0,3355000,7653500,1149500,-226500,,-4525000,-4525000,173297000.0,18503000.0,14737000.0,5384000.0,33240000.0,16175000.0,-183177000.0,5652000.0,8442000.0,118000.0,11260000.0,12570000.0,8616000.0,1999000.0,31123000.0,15011000.0,878000.0,3673000.0,2073000.0,-7500000,-1723500,-7710500,-152500,9739500,58500,9987000,-2736000,-53000,-4712000,249500,-24000,69500,774500,-95000,384500,-186500,18553000.0,en-US,US,EQUITY,False,Delayed Quote,USD,10.8,1629921592,0.0,8.78,10.8,10.8,7418,0.0,10.8 - 10.8,10.8,finmb_29898934,Other OTC,IceCure Medical Ltd,ILS,7968,40264,10.62,58.999996,0.18 - 88.0,-77.2,-0.87727267,0.18,88.0,2,PNK,12.643894,-1.843894,-0.14583276,9.26058,1.5394201,0.16623366,2827386112,15,America/New_York,EDT,-14400000,False,False,0,ICECURE MEDICAL LTD,us_market,PRE,1.41,,,88.0,0.18,12.64,9.26,7.97k,40.26k,254.14M,,80.5M,53.55%,0.00%,,,,,,,,,,,0.00%,,,,,"Dec 30, 2020","Dec 30, 2020",-114.83%,0.00%,-29.93%,-126.57%,,,80.20%,8.55M,,,,,,,,6.57,2.48,,,,Value,3079504,Healthcare,40,"IceCure Medical Ltd develops and markets minimally invasive cryoablation therapies for women's health and oncology markets. It offers ProSense system, a cryoablation solution for breast tumors. The company was founded in 2006 and is headquartered in Caesarea, Israel.",Caesarea,972 4 623 0333,Israel,http://www.icecure-medical.com,86400,7 HaâEshel Street,972 4 623 0222,Medical Care Facilities,PO Box 3163
t-1,ICUSF,14737000.0,254142000,4001000,,-4525000,,-4525000,2503000,2205500,-4298500,-4298500,,-22000,,,,0,3355000,7653500,1149500,-226500,,-4525000,-4525000,173297000.0,18503000.0,14737000.0,5384000.0,33240000.0,16175000.0,-183177000.0,5652000.0,8442000.0,118000.0,11260000.0,12570000.0,8616000.0,1999000.0,31123000.0,15011000.0,878000.0,3673000.0,2073000.0,-7500000,-1723500,-7710500,-152500,9739500,58500,9987000,-2736000,-53000,-4712000,249500,-24000,69500,774500,-95000,384500,-186500,18553000.0,en-US,US,EQUITY,False,Delayed Quote,USD,10.8,1629921592,0.0,8.78,10.8,10.8,7418,0.0,10.8 - 10.8,10.8,finmb_29898934,Other OTC,IceCure Medical Ltd,ILS,7968,40264,10.62,58.999996,0.18 - 88.0,-77.2,-0.87727267,0.18,88.0,2,PNK,12.643894,-1.843894,-0.14583276,9.26058,1.5394201,0.16623366,2827386112,15,America/New_York,EDT,-14400000,False,False,0,ICECURE MEDICAL LTD,us_market,PRE,1.41,,,88.0,0.18,12.64,9.26,7.97k,40.26k,254.14M,,80.5M,53.55%,0.00%,,,,,,,,,,,0.00%,,,,,"Dec 30, 2020","Dec 30, 2020",-114.83%,0.00%,-29.93%,-126.57%,,,80.20%,8.55M,,,,,,,,6.57,2.48,,,,Value,3079504,Healthcare,40,"IceCure Medical Ltd develops and markets minimally invasive cryoablation therapies for women's health and oncology markets. It offers ProSense system, a cryoablation solution for breast tumors. The company was founded in 2006 and is headquartered in Caesarea, Israel.",Caesarea,972 4 623 0333,Israel,http://www.icecure-medical.com,86400,7 HaâEshel Street,972 4 623 0222,Medical Care Facilities,PO Box 3163
t-2,ICUSF,3513000.0,254142000,2557000,,-3016000,,-3016000,2225500,2068500,-2714000,-2714000,,-330500,,,,0,3212000,5926000,1143500,-302000,,-3016000,-3016000,157442000.0,21616000.0,3513000.0,8863000.0,25129000.0,12029000.0,-174127000.0,7054000.0,8169000.0,161000.0,16732000.0,14036000.0,8343000.0,1771000.0,23197000.0,,2653000.0,3812000.0,1520000.0,-7500000,1891500,-196000,-124000,-179000,702000,9987000,-1637500,3000,-1265500,178500,-24000,-664000,-897000,-55000,539500,-196000,9161000.0,en-US,US,EQUITY,False,Delayed Quote,USD,10.8,1629921592,0.0,8.78,10.8,10.8,7418,0.0,10.8 - 10.8,10.8,finmb_29898934,Other OTC,IceCure Medical Ltd,ILS,7968,40264,10.62,58.999996,0.18 - 88.0,-77.2,-0.87727267,0.18,88.0,2,PNK,12.643894,-1.843894,-0.14583276,9.26058,1.5394201,0.16623366,2827386112,15,America/New_York,EDT,-14400000,False,False,0,ICECURE MEDICAL LTD,us_market,PRE,1.41,,,88.0,0.18,12.64,9.26,7.97k,40.26k,254.14M,,80.5M,53.55%,0.00%,,,,,,,,,,,0.00%,,,,,"Dec 30, 2020","Dec 30, 2020",-114.83%,0.00%,-29.93%,-126.57%,,,80.20%,8.55M,,,,,,,,6.57,2.48,,,,Value,3079504,Healthcare,40,"IceCure Medical Ltd develops and markets minimally invasive cryoablation therapies for women's health and oncology markets. It offers ProSense system, a cryoablation solution for breast tumors. The company was founded in 2006 and is headquartered in Caesarea, Israel.",Caesarea,972 4 623 0333,Israel,http://www.icecure-medical.com,86400,7 HaâEshel Street,972 4 623 0222,Medical Care Facilities,PO Box 3163
t-3,ICUSF,3513000.0,254142000,2557000,,-3016000,,-3016000,2225500,2068500,-2714000,-2714000,,-330500,,,,0,3212000,5926000,1143500,-302000,,-3016000,-3016000,157442000.0,21616000.0,3513000.0,8863000.0,25129000.0,12029000.0,-174127000.0,7054000.0,8169000.0,161000.0,16732000.0,14036000.0,8343000.0,1771000.0,23197000.0,,2653000.0,3812000.0,1520000.0,-7500000,1891500,-196000,-124000,-179000,702000,9987000,-1637500,3000,-1265500,178500,-24000,-664000,-897000,-55000,539500,-196000,9161000.0,en-US,US,EQUITY,False,Delayed Quote,USD,10.8,1629921592,0.0,8.78,10.8,10.8,7418,0.0,10.8 - 10.8,10.8,finmb_29898934,Other OTC,IceCure Medical Ltd,ILS,7968,40264,10.62,58.999996,0.18 - 88.0,-77.2,-0.87727267,0.18,88.0,2,PNK,12.643894,-1.843894,-0.14583276,9.26058,1.5394201,0.16623366,2827386112,15,America/New_York,EDT,-14400000,False,False,0,ICECURE MEDICAL LTD,us_market,PRE,1.41,,,88.0,0.18,12.64,9.26,7.97k,40.26k,254.14M,,80.5M,53.55%,0.00%,,,,,,,,,,,0.00%,,,,,"Dec 30, 2020","Dec 30, 2020",-114.83%,0.00%,-29.93%,-126.57%,,,80.20%,8.55M,,,,,,,,6.57,2.48,,,,Value,3079504,Healthcare,40,"IceCure Medical Ltd develops and markets minimally invasive cryoablation therapies for women's health and oncology markets. It offers ProSense system, a cryoablation solution for breast tumors. The company was founded in 2006 and is headquartered in Caesarea, Israel.",Caesarea,972 4 623 0333,Israel,http://www.icecure-medical.com,86400,7 HaâEshel Street,972 4 623 0222,Medical Care Facilities,PO Box 3163
